Abstract: Compounds of formula (I) that are capable of acting as purine receptor antagonists, pharmaceutical compositions including the compounds, and methods of making the compounds, are disclosed. The compounds and compositions can be used in treating or preventing disorders related to purine receptor hyperfunctioning.

Abstract: A redundant power supply motherboard assembly connects control segments of a fieldbus-type control system to a host computer. The assembly has a compact design with pairs of power supply modules in side-by-side nests on the motherboard. The nests are mounted on the motherboard in desired locations and securely hold the modules on the assembly despite vibrations, shocks and handling to prevent contact impairment. The nests provide touch protection for components on the motherboard.

Abstract: A redundant power supply motherboard assembly connects control segments of a fieldbus-type control system to a host computer. The assembly has a compact design with pairs of power supply modules mounted in nests on the motherboard. The nests securely hold the modules to prevent contact impairment due to vibrations, shocks and handling.

Abstract: Compounds of formula (I) that are capable of acting as purine receptor antagonists, pharmaceutical compositions including the compounds, and methods of making the compounds, are. disclosed. The compounds and compositions can be used in treating or preventing disorders related to purine receptor hyperfunctioning.

Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and can include one or more of an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.

Abstract: A surge protection system including a pluggable surge protection cartridge and its corresponding base is disclosed. The cartridge includes a housing, a surge protection assembly situated within the housing containing a surge protection element and a plurality of cartridge contacts in electrical contact with the surge protection assembly. The cartridge contacts are configured to engage a base within an electrical load center to carry a surge current from the load center across an electrical path of the surge protection assembly through the surge protection element. The cartridge is configured to be situated within the base such that the cartridge is removable from the base while the base remains in electrical contact with the load center.

Abstract: An inflated implant within an anatomical structure, such as the bladder, may require removal. A method of removing an inflated implant from an anatomical structure can include any of a number of different steps. A removal device can be placed within the anatomical structure. The implant is located within the anatomical structure. After it is located, the implant can be engaged by arms of the removal device. A portion of a surface of the implant can be compromised such that an inflation substance within the implant can escape. The inflation substance can be removed out of the implant through a deflation tube in at least one of the arms used to engage the implant. The implant can then be removed from the anatomical structure.

Abstract: Method and system for treating a patient using an inflatable device. A removal device may be used to remove the inflatable device from the body. The removal device can have at least one manually-actuatable member and at least two opposing jaws at a distal end. At least one of the at least two jaws can be movable by actuation of the at least one manually-actuatable member. At least one of the at least two jaws can have a puncturing member.

Abstract: Compounds of formula (I) that are capable of acting as purine receptor antagonists, pharmaceutical compositions including the compounds, and methods of making the compounds, are disclosed. The compounds and compositions can be used in treating or preventing disorders related to purine receptor hyperfunctioning.

Abstract: A terminal block is disclosed that includes a terminal body housing, a plurality of conductive elements arranged within the terminal body to create a continuous electrical path therethrough, and a disconnect switch integral the terminal body, the switch arranged to open the continuous electrical path and expose a terminal.

Abstract: A method of delivering a medical fluid to a patient includes enabling the attachment of an infusion pump housing to an external support, enabling the viewing of information right-side-up on a display screen of the infusion pump housing, enabling the rotation of the display screen approximately 90 degrees about an axis extending perpendicularly from the display screen, automatically reorienting the information on the display screen so that the information remains right-side-up after rotation, enabling the viewing of the information right-side-up on the display screen after rotation, and enabling the delivery of a flowable material to the patient through an infusion line attached to the infusion pump housing before and after rotation.

Abstract: The present invention provides food products, nutritional programs, and methods for meeting nutritional needs of subjects with dementia and related cognitive disorders. In one embodiment, the invention provides a food product comprising a reversibly sealed container and a soup, wherein the soup is in the container and comprises a total volume of 200-2000 mls, a vegetable or meat component, 300 to 2500 calories, a macronutrient caloric distribution comprising: 20-80% fat, 10-45% protein, and 10-65% carbohydrate, about 2% to about 40% medium chain triglycerides, omega 3 fatty acids in an amount of 100 to 2000 mg and less than 20 solid food particles having a volume greater than about 20 cm3.

Abstract: A method for identifying cancer patients that are likely to be responders or non-responders to a signal transduction pathway inhibitor is described.

Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.

Abstract: An infusion pump including a drive mechanism; an assembly operable with the drive mechanism, the assembly configured to deliver a flowable material to a patient; a mountable housing holding the drive mechanism and configured at its front side to receive the assembly and at its backside to mount in either a first orientation or a second orientation to an external support, wherein the housing supports the drive mechanism and the assembly in each of the orientations; a controller operably connected to the housing; and a display operably connected to the controller and supported by the front side of the housing, the display configured to be rotatably responsive so that information displayed by the display is oriented right-side-up regardless of whether the assembly is in the first orientation or the second orientation.

Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and can include one or more of an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.

Abstract: A method for locally reinforcing or baffling a structure having a hollow cavity is disclosed. The present invention provides an insert that includes a carrier, a thermally expandable material located on at least a portion of the carrier, and at least one integrally formed attachment that projects outwardly from the carrier. The inserts of the present invention are preferably placed within a hollow cavity in a transverse direction so that once the insert is sealed into place via the thermally expandable material, the hollow cavity is separated into two separate chambers.

Abstract: Method and system for treating a patient using an inflatable device. A removal device may be used to remove the inflatable device from the body. The removal device can have at least one manually-actuatable member and at least two opposing jaws at a distal end. At least one of the at least two jaws can be movable by actuation of the at least one manually-actuatable member. At least one of the at least two jaws can have a puncturing member.

Abstract: The present invention is predicated upon methods and devices for positively mounting structural members while preventing or substantially limiting exposure of such members to environmental conditions possibly leading to corrosion.